Bal Pharma Income Statement

Quarterly

Yearly

home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
2022
EBITDA29
EBIT20
Earning Per Share3
Expenses258
Net Profit6
Net Profit Margin2
Operating Profit Margin10
Profit Before Tax9
Dividends Per Share0
Operation Revenue286

Peer Comparison (in ₹.Cr.)

CompanyYearEBITEBITDANet ProfitNet WorthProfit Before Tax
2023008,560.84NA9,408.43
2023002,835.49NA4,038.35
202300372.90NA385.50
202300103.87NA140.39
20221,257.602,182.90978.507,628.101,190
The EBITDA of Bal Pharma is 29 as of 3/4/2024
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20092009200920092023
Operating Activities13131313-2
Investing Activities-11-11-11-11-22
Financing Activities-3-3-3-324
Others00000
Net Cash Flow-1-1-1-10

Peer Comparison (in ₹.Cr.)

CompanyYearOperating ActivitiesInvesting ActivitiesFinancing ActivitiesNet Cash Flow
20234,959.33-7,943.682,376.07-608.28
20203,068.45104.04-2,948.82223.67
2018312.42-884.38502.63-69.33
2020140.90-44.50-38.5557.85
2017640-498.50-177.50-36
The cash flow from Operating Activities of Bal Pharma is -2 as of 3/4/2024